Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
Gross margin
€ 50,247
▲ 177% vs 2024
Profit
Growing€ 38,859
▲ 1347% vs 2024
Debts
High€ 1.3 million
▲ 42% vs 2024
IQVIA Cancer Research from Zaventem, company number BE0763914095, closed financial year 2025 with a result of € 38,859 after tax. For that financial year IQVIA Cancer Research recorded a gross margin of € 50,247 and equity of € -269,667. Compared with financial year 2024, the result moved from € 2,686 to € 38,859. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.
What happened at IQVIA Cancer Research?
What happened at IQVIA Cancer Research in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 38,859 (▲ 1347% vs 2024). Source: NBB ↗
- Robert Kotchie became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 91,252 loss in 2021 to € 38,859 profit in 2025.
Best year ever: 2025, with € 38,859 profit.
A new publication or filing at IQVIA Cancer Research? We notify you, reason included.
Follow IQVIA Cancer ResearchNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind IQVIA Cancer Research is Robert Kotchie. The shares are held by IQVIA LTD (100%).
Directors
According to the 2025 annual accounts
Robert Kotchie
Gedelegeerd bestuurder
since 2021
Shareholders
IQVIA LTD
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Da Vincilaan 7
1930 Zaventem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
IQVIA Solutions Belgium
€ 33.1 million revenue · 2025
TAKEDA BELGIUM
€ 201.4 million revenue · 2025
IQVIA RDS & INTEGRATED SERVICES BELGIUM
€ 45.6 million revenue · 2025
IM ASSOCIATES
€ 3.1 million gross margin · 2025
Orifarm Healthcare
€ 31.3 million revenue · 2025
+2 more
Details
- Company number
- 0763.914.095
- VAT number
- BE 0763.914.095
- Registered office
- Da Vincilaan 7, 1930 Zaventem
- Names & denominations
- IQVIA Cancer Research
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 February 2021
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied